文献速递痛风与晶体性关节病

减重手术对肥胖伴或不伴高尿酸血症和痛风患者血尿酸的影响:回顾性分析

Effects of bariatric surgery on serum uric acid in people with obesity with or without hyperuricaemia and gout: a retrospective analysis.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该回顾性分析纳入147例接受减重手术的肥胖患者,评估术前及术后1-7天、1、3、6、12个月体重和血尿酸变化。术后1年平均减重30.7 kg,血尿酸从基线419.0 µmol/l降至12个月327.9 µmol/l,呈先降后升再降趋势;痛风患者降幅更大,部分降至目标以下。

要点

  • 减重手术可显著降低肥胖患者血尿酸,术后1年平均降幅84.3 µmol/l。
  • 血尿酸术后1-7天快速下降,1个月反跳升高,之后再次逐渐下降。
  • 痛风患者血尿酸降幅达163.6 µmol/l,部分12个月降至目标以下。

核心结论

  • 减重手术可显著降低肥胖伴高尿酸血症和痛风患者的体重及血尿酸水平。
  • 痛风可被视为严重肥胖患者接受减重手术的指征。

研究设计与样本

  • 回顾性分析147例常规收集的接受减重手术的肥胖住院患者数据。
  • 在基线及术后1-7天、1、3、6、12个月测量体重和血尿酸。

主要发现

  • 147例患者术后1年平均减重30.7 kg(95%CI 28.7-32.7),P<0.001。
  • 血尿酸从基线419.0 µmol/l(95%CI 400.1-437.8)降至术后1-7天308.4 µmol/l(95%CI 289.6-327.2)。
  • 血尿酸在术后1个月升至444.8 µmol/l(95%CI 423.9-465.6),3个月降至383.8 µmol/l(95%CI 361.5-406.1),6个月348.9 µmol/l(95%CI 326.3-371.5),12个月327.9 µmol/l(95%CI 305.3-350.5),P<0.001。
  • 55例高尿酸血症和25例痛风患者呈现相似但更快速的下降趋势。
  • 25例痛风患者基线血尿酸均高于治疗目标(≥360 µmol/l),其中10例在12个月时降至目标以下。

临床怎么用

  • 对严重肥胖合并痛风患者,可考虑将减重手术作为降低血尿酸的治疗选择。
  • 术后需监测血尿酸动态变化,注意1个月左右的反跳升高。

局限性

  • 本研究为回顾性分析,证据等级有限。
  • 样本来自单中心常规收集数据,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Weight reduction may reduce serum uric acid (SUA). This study aimed to examine the changes of SUA before and after bariatric surgery in patients with obesity with or without hyperuricaemia and gout. METHODS: This is a retrospective analysis of 147 routinely collected data on hospital patients with obesity who underwent bariatric surgery. The body weight and SUA were measured at baseline and after surgery at 1-7 days, 1, 3, 6 and 12 months. RESULTS: The mean (95% CI) weight reduction of 147 patients was 30.7 (28.7, 32.7) kg 1 year after surgery (P < 0.001). SUA decreased rapidly from 419.0 (400.1, 437.8) µmol/l at baseline to 308.4 (289.6, 327.2) µmol/l at 1-7 days, flared up to 444.8 (423.9, 465.6) µmol/l at 1 month, then decreased again to 383.8 (361.5, 406.1) µmol/l at 3 months, 348.9 (326.3, 371.5) µmol/l at 6 months and 327.9 (305.3, 350.5) µmol/l at 12 months (P < 0.001). Similar trends but more rapid reductions were observed in 55 hyperuricaemia patients and 25 gout patients. All 25 gout patients had an elevated SUA above the therapeutic target (≥360µmmol/l) at baseline, but in 10 patients it was reduced below this target at 12 months. The mean reduction (95% CI) of SUA in all patients and gout patients was 84.3 (63.1-105.4) and 163.6 (103.9, 223.3) µmmol/l, respectively. CONCLUSION: Bariatric surgery significantly reduces body weight and SUA for obese patients with hyperuricaemia and gout. Gout may be considered as an indicator for this surgical treatment in people with severe obesity.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Lu J, Bai Z, Chen Y, et al. Effects of bariatric surgery on serum uric acid in people with obesity with or without hyperuricaemia and gout: a retrospective analysis. Rheumatology (Oxford). 2021. PMID: 33394025. doi:10.1093/rheumatology/keaa822

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。